His primary areas of investigation include Internal medicine, Endocrinology, Cortisone, Glucocorticoid and 11β-hydroxysteroid dehydrogenase type 1. Internal medicine is frequently linked to Isozyme in his study. His study in Endocrinology focuses on Mineralocorticoid, Hydrocortisone, Mineralocorticoid receptor, Adipose tissue and Kidney.
Paul M. Stewart combines subjects such as In vivo and Glycyrrhiza with his study of Cortisone. Paul M. Stewart does research in Glucocorticoid, focusing on Glucocorticoid receptor specifically. His 11β-hydroxysteroid dehydrogenase type 1 study combines topics from a wide range of disciplines, such as Insulin and Insulin resistance.
Paul M. Stewart mainly focuses on Internal medicine, Endocrinology, Glucocorticoid, Cortisone and 11β-hydroxysteroid dehydrogenase type 1. His work is connected to Hydrocortisone, Mineralocorticoid receptor, Acromegaly, Aldosterone and Corticosterone, as a part of Internal medicine. His Hydrocortisone research is multidisciplinary, relying on both Corticosteroid and Adrenal insufficiency.
The study incorporates disciplines such as Octreotide and Somatostatin in addition to Acromegaly. Paul M. Stewart integrates several fields in his works, including Endocrinology and Context. His research on Cortisone often connects related topics like Isozyme.
His primary areas of study are Internal medicine, Endocrinology, Glucocorticoid, Adrenal insufficiency and Hydrocortisone. His Internal medicine research focuses on Diabetes mellitus and how it relates to Obesity. Paul M. Stewart studied Endocrinology and 11β-hydroxysteroid dehydrogenase type 1 that intersect with Myopathy.
The Glucocorticoid study combines topics in areas such as Area under the curve, Myogenesis, Skeletal muscle, Hypopituitarism and Bone remodeling. His research in Adrenal insufficiency intersects with topics in Adverse effect, Pediatrics and Intensive care medicine. His research investigates the connection between Polycystic ovary and topics such as Androgen that intersect with issues in Androgen Excess.
Paul M. Stewart focuses on Internal medicine, Endocrinology, Glucocorticoid, Context and Cortisone. His study in Insulin resistance, Androgen, Adipose tissue, Adverse effect and Urinary system is carried out as part of his studies in Internal medicine. His Adipose tissue research is multidisciplinary, incorporating elements of Microdialysis and Insulin.
His study in 11β-hydroxysteroid dehydrogenase type 1 extends to Endocrinology with its themes. His Glucocorticoid research incorporates elements of Cell culture, Inflammatory arthritis, Arthritis, Bone remodeling and Pharmacology. His biological study deals with issues like Biochemistry, which deal with fields such as Physiology and Glucose homeostasis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Lynnette K. Nieman;Beverly M. K. Biller;James W. Findling;John Newell-Price.
The Journal of Clinical Endocrinology and Metabolism (2008)
Corticosteroid insufficiency in acutely ill patients.
Mark S Cooper;Paul M Stewart.
The New England Journal of Medicine (2003)
LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR
C.R.W. Edwards;D. Burt;M.A. Mcintyre;E.R. De Kloet.
The Lancet (1988)
Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.
Daniel Zehnder;Rosemary Bland;Mary C. Williams;Robert W. McNinch.
The Journal of Clinical Endocrinology and Metabolism (2001)
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
Jeremy W. Tomlinson;Elizabeth A. Walker;Iwona J. Bujalska;Nicole Draper.
Endocrine Reviews (2004)
Association between premature mortality and hypopituitarism
J. W. Tomlinson;N. Holden;Robert Kerrin Hills;K. Wheatley.
The Lancet (2001)
11 beta-Hydroxysteroid dehydrogenase.
Paul M. Stewart;Zygmunt S. Krozowski.
Vitamins and Hormones Series (1999)
MINERALOCORTICOID ACTIVITY OF LIQUORICE: 11-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY COMES OF AGE
P. M. Stewart;A. M. Wallace;R. Valentino;D. Burt.
The Lancet (1987)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
Trainer Pj;Drake Wm;Katznelson L;Freda Pu.
The New England Journal of Medicine (2000)
Does central obesity reflect Cushing's disease of the omentum?
Iwona J Bujalska;Sudhesh Kumar;Paul M Stewart.
The Lancet (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: